PineBridge Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.8M Buy
1,666,733
+1,233,402
+285% +$32.8M 0.39% 52
2025
Q4
$10.8M Buy
433,331
+163,071
+60% +$4.11M 0.08% 171
2025
Q3
$6.89M Buy
+270,260
New +$6.67M 0.05% 233
2025
Q2
Sell
-538,284
Closed -$13.6M 703
2025
Q1
$13.6M Buy
+538,284
New +$14.1M 0.11% 184
2024
Q4
Sell
-371,276
Closed -$10.7M 755
2024
Q3
$10.7M Sell
371,276
-32,991
-8% -$962K 0.08% 213
2024
Q2
$11.3M Sell
404,267
-208,994
-34% -$5.75M 0.09% 208
2024
Q1
$17M Buy
613,261
+142,318
+30% +$3.95M 0.14% 170
2023
Q4
$13.6M Sell
470,943
-1,284,612
-73% -$38.8M 0.13% 177
2023
Q3
$58.2M Buy
1,755,555
+306,147
+21% +$10.8M 0.65% 25
2023
Q2
$53.2M Sell
1,449,408
-138,514
-9% -$5.39M 0.57% 31
2023
Q1
$64.8M Buy
1,587,922
+48,475
+3% +$2.09M 0.73% 25
2022
Q4
$78.9M Buy
1,539,447
+35,143
+2% +$1.68M 0.96% 16
2022
Q3
$65.8M Buy
1,504,304
+239,579
+19% +$11.6M 0.85% 20
2022
Q2
$66.3M Buy
1,264,725
+224,751
+22% +$11.5M 0.83% 21
2022
Q1
$53.8M Buy
1,039,974
+507,327
+95% +$26.3M 0.58% 33
2021
Q4
$31.5M Sell
532,647
-51,662
-9% -$2.56M 0.32% 64
2021
Q3
$25.1M Buy
584,309
+37,274
+7% +$1.65M 0.3% 86
2021
Q2
$21.4M Sell
547,035
-193,539
-26% -$7.53M 0.25% 98
2021
Q1
$26.8M Buy
740,574
+311,826
+73% +$11.1M 0.34% 63
2020
Q4
$15.8M Sell
428,748
-847,839
-66% -$31.1M 0.24% 98
2020
Q3
$44.5M Buy
1,276,587
+215,346
+20% +$7.55M 0.77% 20
2020
Q2
$32.9M Buy
1,061,241
+17,847
+2% +$606K 0.63% 32
2020
Q1
$32.3M Sell
1,043,394
-19,022
-2% -$648K 0.76% 29
2019
Q4
$39.5M Sell
1,062,416
-18,052
-2% -$643K 0.61% 35
2019
Q3
$36.8M Sell
1,080,468
-129,898
-11% -$4.72M 0.6% 34
2019
Q2
$49.7M Buy
1,210,366
+647,542
+115% +$25.7M 0.81% 22
2019
Q1
$22.7M Buy
562,824
+22,783
+4% +$912K 0.46% 56
2018
Q4
$22.4M Buy
540,041
+38,037
+8% +$1.58M 0.5% 55
2018
Q3
$21M Sell
502,004
-55,858
-10% -$2.15M 0.4% 75
2018
Q2
$19.2M Buy
557,862
+324,445
+139% +$11.1M 0.47% 48
2018
Q1
$7.86M Sell
233,417
-25,696
-10% -$883K 0.19% 132
2017
Q4
$8.9M Sell
259,113
-77,431
-23% -$2.64M 0.23% 119
2017
Q3
$11.4M Buy
336,544
+69,644
+26% +$2.24M 0.27% 96
2017
Q2
$8.51M Buy
266,900
+3,385
+1% +$107K 0.22% 116
2017
Q1
$8.55M Buy
263,515
+23,479
+10% +$740K 0.22% 119
2016
Q4
$7.4M Sell
240,036
-7,466
-3% -$228K 0.22% 120
2016
Q3
$7.95M Sell
247,502
-34,997
-12% -$1.17M 0.35% 102
2016
Q2
$9.44M Sell
282,499
-630,005
-69% -$20.1M 0.48% 75
2016
Q1
$25.7M Sell
912,504
-317,408
-26% -$9.07M 1.32% 9
2015
Q4
$37.7M Sell
1,229,912
-39,008
-3% -$1.23M 1.62% 6
2015
Q3
$37.8M Buy
1,268,920
+148,206
+13% +$4.75M 1.61% 7
2015
Q2
$35.7M Sell
1,120,714
-3,262
-0.3% -$106K 1.41% 10
2015
Q1
$37.1M Sell
1,123,976
-658
-0.1% -$20.9K 1.37% 10
2014
Q4
$33.2M Buy
1,124,634
+35,559
+3% +$1.02M 1.26% 9
2014
Q3
$30.6M Sell
1,089,075
-327,601
-23% -$9.19M 1.25% 8
2014
Q2
$39.9M Buy
1,416,676
+330,046
+30% +$9.41M 1.58% 5
2014
Q1
$33.1M Sell
1,086,630
-322,177
-23% -$9.61M 1.09% 10
2013
Q4
$40.9M Sell
1,408,807
-136,853
-9% -$3.98M 1.22% 6
2013
Q3
$42.1M Sell
1,545,660
-398,751
-21% -$10.8M 1.3% 7
2013
Q2
$51.7M Buy
+1,944,411
New +$53.7M 1.64% 6

Other funds holding PFE

PineBridge Investments's PFE Position: Q1 2026 in Review

PineBridge Investments increased its Pfizer (PFE) stake by 285% in Q1 2026, buying an estimated $32.8M and bringing the position to 1,666,733 shares worth $46.8M. The position accounts for 0.39% of the portfolio, ranked #52.

PineBridge Investments first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $78.9M in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • PineBridge Investments held 1,666,733 shares of Pfizer worth $46.8M as of Q1 2026.
  • PineBridge Investments bought 1,233,402 Pfizer shares in Q1 2026, an estimated $32.8M.
  • Pfizer made up 0.39% of PineBridge Investments's portfolio in Q1 2026, its #52 holding.
  • PineBridge Investments first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
  • PineBridge Investments's Pfizer position peaked at $78.9M in Q4 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on PineBridge Investments's 13F filing for Q1 2026, filed 14 May 2026.